Earlier this year, U.S. officials awarded a contract worth hundreds of millions of dollars to Phlow, a little-known Virginia company promising to revamp the way medicines are made and distributed. Michelle Miller speaks to the company’s founders about their goal to manufacture affordable, generic drugs in the U.S.
